| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $33,251,480 ) (Continued on the next page) |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115846 | Laboratory for Early Psychosis Research (LEAP) | 001 | 7 | NIH | 9/19/2025 | $1,969,525 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24AA025977 | Mentoring in Patient-Oriented Neuroscience Research | 000 | 9 | NIH | 9/5/2025 | $162,796 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH108665 | Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala Pathways | 002 | 10 | NIH | 5/1/2025 | $659,823 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH108665 | Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala Pathways | 003 | 10 | NIH | 9/25/2025 | $116,438 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32DA015036 | Training in Drug Abuse and Brain Imaging | 001 | 24 | NIH | 6/18/2025 | $5,314 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32DA015036 | Training in Drug Abuse and Brain Imaging | 000 | 24 | NIH | 5/15/2025 | $337,588 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH063266 | Roles of nuleus accumbens CREB and Kappa function in depression | 000 | 25 | NIH | 7/15/2025 | $569,913 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24DA061976 | Mentoring in Patient-Oriented Research on Substance Use Disorders | 000 | 1 | NIH | 12/24/2024 | $208,575 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH126193 | Interpretation Bias as a Mechanism of Treatment Response in OCD | 000 | 4 | NIH | 7/10/2025 | $181,516 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH136052 | MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach | 000 | 1 | NIH | 3/24/2025 | $766,842 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH138861 | Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia | 000 | 1 | NIH | 11/15/2024 | $246,000 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134885 | 3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST) | 001 | 2 | NIH | 8/7/2025 | $373,589 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137459 | A Multilevel Characterization of Sensory Cortical Disinhibition in Post-Traumatic Intrusions | 000 | 2 | NIH | 5/23/2025 | $179,031 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH133268 | Next steps for PTSD genomics: from loci to function | 001 | 2 | NIH | 8/18/2025 | $121,693 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH133268 | Next steps for PTSD genomics: from loci to function | 000 | 2 | NIH | 4/16/2025 | $689,594 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS129188 | Human iPSC-Based Personalized Cell Therapy of PD | 000 | 3 | NIH | 4/18/2025 | $689,100 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS127391 | Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands | 000 | 3 | NIH | 4/25/2025 | $432,440 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R35GM157195 | Decoding the Neural Foundations of Sexual Dimorphisms in Aggression: A Female-Centric Approach | 000 | 1 | NIH | 9/10/2025 | $2,050,000 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 002 | 20 | NIH | 7/24/2025 | $114,641 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 001 | 20 | NIH | 7/24/2025 | $114,641 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 000 | 20 | NIH | 2/19/2025 | $649,636 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UG3DA062906 | Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials | 000 | 1 | NIH | 7/18/2025 | $352,064 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137075 | Personalized Quality of Life Measurement | 000 | 2 | NIH | 8/20/2025 | $561,362 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 001 | 3 | NIH | 1/28/2025 | $111,618 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 003 | 3 | NIH | 4/28/2025 | $0 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 002 | 3 | NIH | 4/25/2025 | $0 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 000 | 3 | NIH | 1/27/2025 | $634,317 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 000 | 2 | NIH | 1/27/2025 | $513,604 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 001 | 2 | NIH | 9/22/2025 | $90,635 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135844 | Harnessing smartphones for real-time detection of affective disturbance and future depression risk in adolescents | 000 | 1 | NIH | 1/31/2025 | $759,581 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135899 | Leveraging Machine Learning Approaches to Understand Mechanisms of Exposure Therapy in Real-World Settings | 000 | 2 | NIH | 2/14/2025 | $659,178 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 002 | 5 | NIH | 4/24/2025 | $0 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 001 | 5 | NIH | 12/5/2024 | $70,946 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 5 | NIH | 11/7/2024 | $649,051 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH136479 | Utilizing circRNA transcriptomics for functional characterization of psychiatric GWAS | 000 | 2 | NIH | 1/8/2025 | $174,250 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH136479 | Utilizing circRNA transcriptomics for functional characterization of psychiatric GWAS | 001 | 2 | NIH | 8/26/2025 | $30,750 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 001 | 4 | NIH | 9/23/2025 | $100,722 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 4 | NIH | 1/13/2025 | $570,762 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 2 | NIH | 12/10/2024 | $762,422 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH133114 | Measuring brain lactate and other metabolites in schizophrenia at 3T using an enhanced MR spectroscopy approach | 001 | 2 | NIH | 9/23/2025 | $30,750 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH133114 | Measuring brain lactate and other metabolites in schizophrenia at 3T using an enhanced MR spectroscopy approach | 000 | 2 | NIH | 4/24/2025 | $174,250 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 2 | NIH | 11/4/2024 | $178,416 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 5 | NIH | 12/9/2024 | $98,546 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AA030585 | Insula-amygdala circuits in alcohol abuse | 000 | 3 | NIH | 8/14/2025 | $516,261 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 3 | NIH | 4/24/2025 | $721,783 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD111352 | Transgenerational Impact of Childhood Maltreatment on Structural/Functional Properties of Visual Cortex | 000 | 6 | NIH | 8/14/2025 | $94,978 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1AG078304 | Combining Computational Methods, RDoC, and Big Neuroimaging Data to Understand Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease | 000 | 2 | NIH | 9/3/2025 | $1,583,985 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K08MH130802 | Understanding Foxp2-Mediated Molecular Signaling in Fear Learning | 000 | 3 | NIH | 4/14/2025 | $193,993 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH139697 | Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression | 000 | 1 | NIH | 6/9/2025 | $777,016 |
|